Buy AOD 9604 5mg – Research Peptide

AOD 9604 is a synthetic peptide studied in laboratory research as a modified fragment associated with human growth hormone (hGH) research. Also identified as AOD-9604, the peptide consists of a 16-amino-acid sequence incorporating a tyrosine residue at the N-terminus. Researchers have investigated AOD 9604 in experimental models to better understand peptide structure, molecular interactions, and biological pathways associated with the modified hGH fragment.

This AOD 9604 research peptide is offered strictly for qualified laboratory research, in-vitro testing, analytical studies, and other non-clinical scientific applications. It is not presented as a product for human or veterinary use. Researchers evaluating AOD 9604 can use the listed molecular characteristics, sequence information, and available analytical documentation to support laboratory identification and experimental planning.

Buy AOD 9604 5mg for Laboratory Research

Researchers seeking to buy AOD 9604 5mg should evaluate the material according to its documented chemical identity, analytical specifications, packaging, and intended laboratory application. AOD 9604 provides a defined peptide sequence suitable for research involving synthetic peptide characterization, analytical comparison, molecular studies, and related in-vitro laboratory work.

The supplied sequence is a 16-residue peptide beginning with tyrosine and containing cysteine residues within the sequence. The reported molecular formula is C78H123N23O23S2, with a molecular mass of approximately 1815.1 g/mol. These characteristics can be used by qualified researchers as reference information when evaluating peptide identity and analytical results.

AOD 9604 Molecular Profile and Scientific Background

AOD 9604 was developed as a modified peptide fragment related to the C-terminal region of human growth hormone. Research literature has examined modified hGH fragments to investigate whether discrete peptide regions can exhibit molecular behavior different from the complete parent protein. AOD 9604 is described as a 16-amino-acid synthetic peptide containing an additional N-terminal tyrosine residue.

From a laboratory perspective, this structural modification makes AOD 9604 relevant to research involving peptide structure, sequence-dependent properties, molecular characterization, and comparative studies of synthetic peptide fragments. Researchers may investigate the material using appropriate analytical techniques designed for peptide identification and characterization.

Published research has also examined AOD 9604 in experimental models. Those studies form part of the scientific background surrounding the compound but should not be interpreted as evidence of clinical performance, safety, or suitability for human use. Experimental findings from animal or laboratory models cannot by themselves establish a product’s safety or effectiveness for people.

AOD 9604 Chemical Specifications & CoA Summary

Specification	Reported Information
Product Name	AOD 9604
Alternative Name	AOD-9604
Peptide Type	Synthetic research peptide
Sequence	Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Molecular Formula	C78H123N23O23S2
Molecular Mass	1815.1 g/mol
Purity	Refer to current batch-specific CoA
Physical Appearance	Lyophilized peptide material; verify current batch documentation
Intended Use	Laboratory research and in-vitro scientific studies only

Certificate of Analysis: Batch-specific analytical documentation should be reviewed for the actual lot being supplied. Do not assume a particular purity percentage or analytical result from the general product description. Where available, researchers should review the applicable CoA for lot-specific identity, purity, and analytical testing information.

Key Laboratory Features & Quality Benchmarks

• Defined peptide sequence: AOD 9604 is identified by a specific 16-amino-acid sequence for laboratory reference and analytical characterization.
• Documented molecular profile: The reported molecular formula is C78H123N23O23S2 with a molecular mass of 1815.1 g/mol.
• Synthetic research material: The product is positioned for controlled laboratory research and non-clinical scientific applications.
• Analytical verification: Researchers should consult the applicable batch-specific CoA for available analytical testing, including HPLC or mass-spectrometry results where provided.
• Lyophilized presentation: Lyophilized peptide material is supplied for laboratory handling and analytical preparation according to the applicable product documentation.
• Research-focused packaging: Researchers should inspect the received container and documentation before laboratory use and maintain appropriate sample-identification records.

Handling, Storage & Laboratory Preparation

AOD 9604 should be handled by appropriately trained laboratory personnel using procedures suitable for synthetic peptide research. Researchers should follow the storage conditions supplied with the specific batch and consult the applicable certificate of analysis or manufacturer documentation when available.

Storage

Because peptide stability can depend on formulation, moisture exposure, temperature, container integrity, and storage duration, the applicable product documentation should take precedence over generic storage assumptions. Keep the material protected from conditions that could compromise peptide integrity, including unnecessary exposure to moisture, heat, and repeated environmental changes.

Laboratory Preparation

For in-vitro research, preparation should be performed according to the requirements of the specific experimental protocol and the researcher’s validated laboratory procedures. Researchers should select appropriate laboratory-grade materials and analytical controls for their intended experiment. Any prepared research solution should be appropriately identified, handled, and stored according to the validated laboratory protocol.

This product page does not provide human-use administration instructions, clinical protocols, or therapeutic preparation instructions. The material is supplied exclusively for non-clinical research applications.

Frequently Asked Questions About AOD 9604

What is AOD 9604?

AOD 9604 is a synthetic 16-amino-acid peptide derived from research involving a modified fragment associated with human growth hormone. It is studied in laboratory research involving peptide structure and molecular characterization.

What is the molecular weight of AOD 9604?

The reported molecular mass of AOD 9604 is 1815.1 g/mol. Researchers should compare this value with the analytical documentation applicable to the specific material and batch.

How can AOD 9604 purity be verified?

Purity should be verified using the current batch-specific Certificate of Analysis and applicable analytical results. Where provided, techniques such as HPLC and mass spectrometry can support characterization of synthetic peptide material. Researchers should rely on the actual lot documentation rather than assuming a generic purity specification.

How should AOD 9604 be stored?

AOD 9604 should be stored according to the conditions specified in the current product documentation and batch records. Appropriate laboratory storage should minimize exposure to environmental conditions that could affect peptide integrity. Researchers should consult the applicable CoA or manufacturer documentation for lot-specific requirements.

Is AOD 9604 intended for human use?

No. This product is supplied strictly for laboratory research, in-vitro testing, analytical studies, and other non-clinical scientific applications. It is not intended for human consumption, clinical use, diagnosis, treatment, or prevention of disease.

Research Use Only Disclaimer

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION.

AOD 9604 is supplied strictly as laboratory research material for qualified scientific research, in-vitro testing, analytical characterization, and other non-clinical applications. This product is not a food, dietary supplement, pharmaceutical product, or clinical diagnostic product. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. It is not intended for administration to humans or animals. No representation is made regarding safety or effectiveness for human or veterinary use. Researchers are responsible for ensuring that their use, handling, storage, documentation, and disposal of the material comply with applicable laws, regulations, institutional requirements, and laboratory safety procedures.

Research-use labeling must accurately reflect the intended use of the material. FDA guidance concerning RUO products emphasizes that RUO labeling is associated with laboratory research and should not be used to represent a product for clinical diagnostic use.